EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, 180 Life Sciences's enterprise value is $0.78 Mil.
180 Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Therefore, 180 Life Sciences's EV-to-Revenue for today is .
The historical rank and industry rank for 180 Life Sciences's EV-to-Revenue or its related term are showing as below:
ATNF's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.18 * Ranked among companies with meaningful EV-to-Revenue only.
The historical data trend for 180 Life Sciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of 180 Life Sciences's EV-to-Revenue
For the Biotechnology subindustry, 180 Life Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
180 Life Sciences's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 180 Life Sciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where 180 Life Sciences's EV-to-Revenue falls into.
180 Life Sciences's current Enterprise Value is $0.78 Mil.
180 Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
180 Life Sciences (NAS:ATNF) EV-to-Revenue Explanation
180 Life Sciences's share price for today is $1.87.
180 Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
180 Life Sciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of 180 Life Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
180 Life Sciences (180 Life Sciences) Business Description
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ATNF has been successfully added to your 